LC
Lunate Capital Ltd
Concentrated strategyHigh-turnover traderQuality / disciplined sizing
Total reported value
$120.4M
Reporting period: 2026-03-31 · Number of holdings: 6
Lunate Capital Ltd disclosed 6 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $120.4M and a quarterly turnover rate of 75.6%.
Personality snowflake
- Concentration
- 100
- Portfolio Stability
- 75.57
- Momentum/Contrarian
- 50
- Sector conviction
- 0
- Diversification
- 12
- Sizing Uniformity
- 89.02
Recent moves
Trim RVMD
-75.0% -$121.5M
Add SAIL
0.0% -$21.0M
Add LINE
0.0% -$1.3M
Add NMRA
0.0% $339.9K
Add NAVN
0.0% -$768.0K
Add RVMDW
0.0% $382.5K
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines INC | Stock-Healthcare | 44.36% | -21.84% | -75.00% | |
| 2 | SAIL | Sailpoint INC | Stock-Other | 33.00% | +10.03% | — | |
| 3 | LINE | Lineage INC | Stock-Other | 16.33% | +8.38% | — | |
| 4 | NMRA | Neumora Therapeutics INC | Stock-Other | 3.44% | +2.00% | — | |
| 5 | NAVN | Navan Inc-cl A | Stock-Other | 2.20% | +0.91% | — | |
| 6 | RVMDW | Revolution Medicines Inc-28 | Stock-Other | 0.67% | +0.51% | — |
Reported value over time
Sector allocation
Sector allocation over time
Quarterly history
Holding changes this quarter
Lunate Capital Ltd's most significant position changes for 2026-03-31: Trim: Revolution Medicines INC (RVMD) — shares -75.00%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SAIL | Sailpoint INC | +10% | — | Unchanged |
| 2 | LINE | Lineage INC | +8.4% | — | Unchanged |
| 3 | NMRA | Neumora Therapeutics INC | +2% | — | Unchanged |
| 4 | NAVN | Navan Inc-cl A | +0.9% | — | Unchanged |
| 5 | RVMDW | Revolution Medicines Inc-28 | +0.5% | — | Unchanged |
| 6 | RVMD | Revolution Medicines INC | -21.8% | -75.00% | Trim |
FAQ
What is Lunate Capital Ltd and what type of investor is it?
Lunate Capital Ltd is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $120.4M, spread across 6 disclosed positions.
What are Lunate Capital Ltd's largest equity positions?
Based on the latest 13F filing, Lunate Capital Ltd's top holdings by market value are:
1. Revolution Medicines INC (RVMD) — $53.4M (44.4%)
2. Sailpoint INC (SAIL) — $39.7M (33.0%)
3. Lineage INC (LINE) — $19.7M (16.3%)
4. Neumora Therapeutics INC (NMRA) — $4.1M (3.4%)
5. Navan Inc-cl A (NAVN) — $2.6M (2.2%)
What changes did Lunate Capital Ltd make in its most recent portfolio filing?
In the latest quarter, Lunate Capital Ltd took a more defensive posture — trimming 1 positions and completely exiting 0 holdings. The largest of these moves: Trim: Revolution Medicines INC (RVMD) — shares -75.00%
What sectors does Lunate Capital Ltd focus on?
Lunate Capital Ltd is concentrated in the following sectors based on its current disclosed equity portfolio:
• Health Care: 100.0%